ILF2 anticorps (C-Term)
-
- Antigène Voir toutes ILF2 Anticorps
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ILF2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Séquence
- C-EKAYEKPPEK KEG
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- ILF2 (NF45, Interleukin enhancer binding factor 2, MGC8391, NF45, PRO3063, Nuclear factor of activated T-cells 45-D)
- Purification
- Purified by peptide affinity chromatography.
- Immunogène
- Synthetic peptide corresponding to C-EKAYEKPPEKKEG, from the internal region (near the C Terminus) of thuman ILF2 (NP_004506.2).
- Isotype
- IgG
- Top Product
- Discover our top product ILF2 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in Tris saline, pH 7.2, 0.5 % BSA, 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- ILF2 (Interleukin Enhancer Binding Factor 2, 45kDa (ILF2))
- Autre désignation
- ILF2 (ILF2 Produits)
- Synonymes
- anticorps nf45, anticorps pro3063, anticorps ILF2, anticorps wu:fb34h01, anticorps zgc:73084, anticorps zgc:77276, anticorps NF45, anticorps PRO3063, anticorps 6230405A16Rik, anticorps TEG-267, anticorps Tex261, anticorps Tex267, anticorps interleukin enhancer binding factor 2, anticorps interleukin enhancer binding factor 2 L homeolog, anticorps ilf2, anticorps ILF2, anticorps ilf2.L, anticorps Ilf2
- NCBI Accession
- NP_004506
- UniProt
- Q12905
-